News | October 08, 2025
Lupin to build $250 million manufacturing facility in Florida
Furthering?U.S.-based?pharmaceutical?capacity?to?produce?critical respiratory medicines?
Furthering?U.S.-based?pharmaceutical?capacity?to?produce?critical respiratory medicines?
Lonza boosts TheraPEAK line with new Cytokines and AAV Medium for next-gen therapies
These products strengthen poultry immunity, improve productivity, and support sustainable farming practices~
The new Houston site, Lilly's eighth U.S. manufacturing facility announced since 2020, will focus on domestic production of small molecule synthetic medicines
Sessions will cover process mapping, cost optimisation, data-driven decision-making, cybersecurity, and sustainable manufacturing practices
This marks the first of four new U.S. manufacturing sites that Lilly plans to announce this year
Encouraging early detection and breaking the silence around men’s health
New unit boosts innovation in liposomal delivery technologies with 8,500 MT capacity and export-ready production
The PLI scheme focuses on incentivizing a strategic shift towards high-value, innovative products such as biologics, complex generics, and specialty formulations
The company’s acquisition of a 51 per cent stake in Saarathi Healthcare earlier this financial year boosted growth
Subscribe To Our Newsletter & Stay Updated
